159 related articles for article (PubMed ID: 37953607)
1. Clinical management of androgen excess and defect in women.
Rosato E; Sciarra F; Minnetti M; Degjoni A; Venneri MA
Expert Rev Endocrinol Metab; 2024; 19(1):21-35. PubMed ID: 37953607
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Amiri M; Kabir A; Nahidi F; Shekofteh M; Ramezani Tehrani F
Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):64-77. PubMed ID: 29457756
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management.
Kostopoulou E; Anagnostis P; Bosdou JK; Spiliotis BE; Goulis DG
Curr Obes Rep; 2020 Sep; 9(3):193-203. PubMed ID: 32504286
[TBL] [Abstract][Full Text] [Related]
5. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
6. Can analysis of serum androgens aid in the diagnosis of polycystic ovary syndrome (PCOS) in adolescents?
Katti N; Paprocki E; Amory JK; Prasad B
Expert Rev Endocrinol Metab; 2022 Sep; 17(5):375-381. PubMed ID: 35923065
[TBL] [Abstract][Full Text] [Related]
7. Androgens and polycystic ovary syndrome.
Nisenblat V; Norman RJ
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
[TBL] [Abstract][Full Text] [Related]
8. Best methods for identification and treatment of PCOS.
Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
[TBL] [Abstract][Full Text] [Related]
9. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
10. Targets to treat androgen excess in polycystic ovary syndrome.
Luque-Ramírez M; Escobar-Morreale HF
Expert Opin Ther Targets; 2015; 19(11):1545-60. PubMed ID: 26549181
[TBL] [Abstract][Full Text] [Related]
11. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada R; Williams T
FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome.
Berbrier DE; Leone CA; Adler TE; Bender JR; Taylor HS; Stachenfeld NS; Usselman CW
J Appl Physiol (1985); 2023 Apr; 134(4):868-878. PubMed ID: 36861670
[TBL] [Abstract][Full Text] [Related]
15. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome in the pediatric population.
Bremer AA
Metab Syndr Relat Disord; 2010 Oct; 8(5):375-94. PubMed ID: 20939704
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
Lanzo E; Monge M; Trent M
Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
[TBL] [Abstract][Full Text] [Related]
18. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
19. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
20. Combined contraceptive pills for androgen excess, not for polycystic ovary syndrome in adolescent girls.
de Zegher F; Ibáñez L
Acta Paediatr; 2024 Jul; 113(7):1481-1482. PubMed ID: 38727034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
